The European Commission issued proposed measures recently that called for moving towards a centralized pre-market authorization system similar to the United States.
The measures are currently being examined, but many stakeholders have already raised concerns that they would delay patient access to medical technologies and unnecessarily thwart innovation in Europe.
"The existing regulatory framework has demonstrated its merits but it has been in...
